Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 6
2019 7
2020 18
2021 11
2022 15
2023 10
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Influence of cannabis use on incidence of psychosis in people at clinical high risk.
Chester LA, Valmaggia LR, Kempton MJ, Chesney E, Oliver D, Hedges EP, Klatsa E, Stahl D, van der Gaag M, de Haan L, Nelson B, McGorry P, Amminger GP, Riecher-Rössler A, Studerus E, Bressan R, Barrantes-Vidal N, Krebs MO, Glenthøj B, Nordentoft M, Ruhrmann S, Sachs G, McGuire P; EU-GEI High Risk Study Group. Chester LA, et al. Among authors: oliver d. Psychiatry Clin Neurosci. 2023 Sep;77(9):469-477. doi: 10.1111/pcn.13555. Epub 2023 May 13. Psychiatry Clin Neurosci. 2023. PMID: 37070555 Free PMC article.
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.
Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, Zandi MS, Lewis G, David AS. Rogers JP, et al. Among authors: oliver d. Lancet Psychiatry. 2020 Jul;7(7):611-627. doi: 10.1016/S2215-0366(20)30203-0. Epub 2020 May 18. Lancet Psychiatry. 2020. PMID: 32437679 Free PMC article.
Ethical considerations for precision psychiatry: A roadmap for research and clinical practice.
Fusar-Poli P, Manchia M, Koutsouleris N, Leslie D, Woopen C, Calkins ME, Dunn M, Tourneau CL, Mannikko M, Mollema T, Oliver D, Rietschel M, Reininghaus EZ, Squassina A, Valmaggia L, Kessing LV, Vieta E, Correll CU, Arango C, Andreassen OA; PSMD EBRA cluster (annex 1). Fusar-Poli P, et al. Among authors: oliver d. Eur Neuropsychopharmacol. 2022 Oct;63:17-34. doi: 10.1016/j.euroneuro.2022.08.001. Epub 2022 Aug 27. Eur Neuropsychopharmacol. 2022. PMID: 36041245 Free article. Review.
Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fraction.
Dragioti E, Radua J, Solmi M, Gosling CJ, Oliver D, Lascialfari F, Ahmed M, Cortese S, Estradé A, Arrondo G, Gouva M, Fornaro M, Batiridou A, Dimou K, Tsartsalis D, Carvalho AF, Shin JI, Berk M, Stringhini S, Correll CU, Fusar-Poli P. Dragioti E, et al. Among authors: oliver d. World Psychiatry. 2023 Feb;22(1):86-104. doi: 10.1002/wps.21068. World Psychiatry. 2023. PMID: 36640414 Free PMC article.
Cannabidiol (CBD) as a novel treatment in the early phases of psychosis.
Chesney E, Oliver D, McGuire P. Chesney E, et al. Among authors: oliver d. Psychopharmacology (Berl). 2022 May;239(5):1179-1190. doi: 10.1007/s00213-021-05905-9. Epub 2021 Jul 13. Psychopharmacology (Berl). 2022. PMID: 34255100 Free PMC article. Review.
Acceptability of cannabidiol in patients with psychosis.
Chesney E, Lamper D, Lloyd M, Oliver D, Hird E, McGuire P. Chesney E, et al. Among authors: oliver d. Ther Adv Psychopharmacol. 2022 Oct 25;12:20451253221128445. doi: 10.1177/20451253221128445. eCollection 2022. Ther Adv Psychopharmacol. 2022. PMID: 36312845 Free PMC article.
69 results